Literature DB >> 126564

Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides.

S Kotani, Y Watanabe, T Shimono, T Narita, K Kato.   

Abstract

1. The cell walls from some 20 species of gram-positive bacteria, with only few exceptions, were found to be definitely adjuvant-active in both stimulation of increased serum antibody levels and induction of delayed-type hypersensitivity to ovalbumin when administered to guinea pigs in the form of a water-in-oil emulsion. 2. By the use of various cell wall lytic enzymes, the immunoadjuvant principles were solubilized with the full retention of adjuvant activities observed with the cell walls of S. aureus, Str. pyogenes, Str. mutans, L. plantarum, C. diphtheriae, Myc. smegmatis and A. viscosus. N-acetylmuramyl peptide monomers (either L-Lys or meso-Dap type) were shown to be the unit chemical structure responsible for the manifestation of adjuvant activities to stimulate both antibody-mediated and cell-mediated immune responses. 3. Several N-Acetylmuramyl peptides were prepared by condensation of benzyl N-acetyl-4,6-O-benzylidene-alpha-muramide with each peptide benzyl ester by means of dicyclohexylcarbodiimide-N-hydroxysuccinimide method and removal of the protecting groups by hydrogenolysis. N-acetylmuramyl-L-alanyl-D-isoglutamine was identified as the minimum structural entity essential for the immunoadjuvant activities characteristic of bacterial cell walls. Neither synthetic N-acetylmuramyl-L-alanine nor L-alanyl-D-isoglutaminyl-L-lysyl-D-alanin was found to be active.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126564

Source DB:  PubMed          Journal:  Z Immunitatsforsch Exp Klin Immunol        ISSN: 0300-872X


  19 in total

Review 1.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 2.  Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

Authors:  Charles Maisonneuve; Sylvie Bertholet; Dana J Philpott; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

3.  Mitogenic activity of staphylococcal peptidoglycan.

Authors:  R Dziarski; A Dziarski
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  Soluble peptidoglycan from Staphylococcus aureus is a murine B-lymphocyte mitogen.

Authors:  U M Babu; A R Zeiger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

5.  Cell walls, peptidoglycans, and teichoic acids of Gram-positive bacteria as polyclonal inducers and immunomodulators of proliferative and lymphokine responses of human B and T lymphocytes.

Authors:  L Räsänen; H Arvilommi
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Relationships between adjuvant, immunosuppressive, and mitogenic activities of staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Successful immunization with a totally synthetic diphtheria vaccine.

Authors:  F Audibert; M Jolivet; L Chedid; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.

Authors:  O Kohashi; S Kotani; T Shiba; A Ozawa
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

9.  Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis.

Authors:  Y C Kong; F Audibert; A A Giraldo; N R Rose; L Chedid
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

10.  Nonhematopoietic cells control the outcome of infection with Listeria monocytogenes in a nucleotide oligomerization domain 1-dependent manner.

Authors:  Ahmed Mosa; Christian Trumstedt; Emma Eriksson; Oliver Soehnlein; Frank Heuts; Katrin Janik; Andreas Klos; Oliver Dittrich-Breiholz; Michael Kracht; Asa Hidmark; Hans Wigzell; Martin E Rottenberg
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.